EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

R1205H (Vicenza) causes conformational changes in the von Willebrand factor D′D3 domains and enhances von Willebrand factor binding to clearance receptors LRP1 and SR-AI

Ferdows Atiq, Orla Rawley, Jamie M O'Sullivan, Mehmet Özbil, Dearbhla Doherty, Niamh Cooke, Virginie Terraube, Alain Chion, Aamir Amin, Anne-Marije Hulshof, Bogdan Baci, Ciara Byrne und 3 weitere

Journal of Thrombosis and Haemostasis · 2024

DOI: 10.1016/j.jtha.2024.06.023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2024. Verfasst von Ferdows Atiq und 14 weiteren Autor:innen. Beteiligte Einrichtung: Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland. Hauptthemen laut MEDLINE: Low Density Lipoprotein Receptor-Related Protein-1, Protein Binding, Protein Domains, von Willebrand Factor. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIH, ZonMw.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: von Willebrand factor (VWF)-R1205H variant (Vicenza) results in markedly enhanced VWF clearance in humans that has been shown to be largely macrophage-mediated. However, the biological mechanisms underlying this enhanced clearance remain poorly understood. OBJECTIVES: This study aimed to investigate the roles of (i) specific VWF domains and (ii) different macrophage receptors in regulating enhanced VWF-R1205H clearance. METHODS: In vivo clearance of full-length and truncated wild-type (WT)-VWF and VWF with R1205 substitutions was investigated in VWF-/- mice. Plate-binding assays were employed to characterize VWF binding to purified scavenger receptor class A member 1 (SR-AI), low-density lipoprotein receptor-related protein-1 (LRP1) cluster II or cluster IV receptors, and macrophage galactose-type lectin. RESULTS: In full-length VWF missing the A1 domain, introduction of R1205H led to significantly enhanced clearance in VWF-/- mice compared with WT-VWF missing the A1 domain. Importantly, R1205H in a truncated VWF-D'D3 fragment also triggered increased clearance compared with WT-VWF-D'D3. Additional in vivo studies demonstrated that VWF-R1205K (which preserves the positive charge at 1205) exhibited normal clearance, whereas VWF-R1205E (which results in loss of the positive charge) caused significantly enhanced clearance, pinpointing the importance of the positive charge at VWF-R1205. In vitro plate-binding studies confirmed increased VWF-R1205H interaction with SR-AI compared with WT-VWF. Furthermore, significantly enhanced VWF-R1205H binding to LRP1 cluster IV (P < .001) and less marked enhanced binding to LRP1 cluster II (P = .034) was observed. In contrast, VWF-R1205H and WT-VWF demonstrated no difference in binding affinity to macrophage galactose-type lectin. CONCLUSION: Disruption of the positive charge at amino acid R1205 causes conformational changes in the VWF-D'D3 domains and triggers enhanced LRP1-mediated and SR-AI-mediated clearance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Low Density Lipoprotein Receptor-Related Protein-1Protein BindingProtein Domainsvon Willebrand FactorAnimalsHumansMiceMacrophagesMice, Inbred C57BLMice, KnockoutProtein ConformationScavenger Receptors, Class B

Stichwörter der Autor:innen

VWF-R1205H (Vicenza)enhanced VWF clearancetype 1C VWDvon Willebrand diseasevon Willebrand factor

Substanzen

Low Density Lipoprotein Receptor-Related Protein-1Lrp1 protein, mouseScarb1 protein, mouseScavenger Receptors, Class Bvon Willebrand Factor

Autor:innen und Institutionen

  • Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada.
  • Computational Biochemistry Group, Gebze Technical University, Institute of Biotechnology, Gebze, Kocaeli, Turkey.
  • BioMedicine Design, Pfizer, Grange Castle, Dublin, Ireland.
  • Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland; National Coagulation Centre, St James's Hospital, Dublin, Ireland. Electronic addre…

Förderung

  • NHLBI NIH HHS
  • NIH
  • ZonMw
  • Science Foundation Ireland

Zitieren

APA

Atiq, F., Rawley, O., O'Sullivan, J. M., Özbil, M., Doherty, D., Cooke, N., Terraube, V., Chion, A., Amin, A., Hulshof, A. M., Baci, B., Byrne, C., Aburawi, H. E., Lillicrap, D., & O'Donnell, J. S. (2024). R1205H (Vicenza) causes conformational changes in the von Willebrand factor D′D3 domains and enhances von Willebrand factor binding to clearance receptors LRP1 and SR-AI. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2024.06.023

Vancouver

Atiq F, Rawley O, O'Sullivan JM, Özbil M, Doherty D, Cooke N, et al. R1205H (Vicenza) causes conformational changes in the von Willebrand factor D′D3 domains and enhances von Willebrand factor binding to clearance receptors LRP1 and SR-AI. Journal of Thrombosis and Haemostasis. 2024. doi:10.1016/j.jtha.2024.06.023

BibTeX
@article{Atiq2024,
  author = {Atiq, Ferdows and Rawley, Orla and O'Sullivan, Jamie M and Özbil, Mehmet and Doherty, Dearbhla and Cooke, Niamh and Terraube, Virginie and Chion, Alain and Amin, Aamir and Hulshof, Anne-Marije and Baci, Bogdan and Byrne, Ciara and Aburawi, Hanan E and Lillicrap, David and O'Donnell, James S},
  title = {R1205H (Vicenza) causes conformational changes in the von Willebrand factor D′D3 domains and enhances von Willebrand factor binding to clearance receptors LRP1 and SR-AI},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2024},
  doi = {10.1016/j.jtha.2024.06.023}
}
Kostenlos starten →